The Heart Group of Lancaster General Health — Lancaster, Pennsylvania

The Heart Group of Lancaster General Health is a clinical research site located in Lancaster, Pennsylvania, United States 17603.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

The Heart Group of Lancaster General Health has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Transthyretin Amyloid Cardiomyopathy (ATTR CM), ASCVD.

Sponsors: Novo Nordisk A/S, Amgen.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Heart Group of Lancaster General Health?

The Heart Group of Lancaster General Health has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Heart Group of Lancaster General Health conducted?

The Heart Group of Lancaster General Health has 2 clinical trials on record, with 1 currently active. Their work covers Transthyretin Amyloid Cardiomyopathy (ATTR CM), ASCVD.

Is The Heart Group of Lancaster General Health accredited by Crixeo Health?

The Heart Group of Lancaster General Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Heart Group of Lancaster General Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.